Peptide Allergens and Fillers

Peptides, like other large molecules, can potentially trigger allergic reactions in susceptible individuals. Allergenicity depends on the peptide's structure, the individual's immune response, and prior exposure. Some peptides are more allergenic than others.

Most pure, well-characterised peptides have low intrinsic allergenicity.

Contaminating proteins (bacterial proteins, manufacturing residues) may be more allergenic than the target peptide. If a peptide preparation contains contaminants from gram-negative bacteria, endotoxins can trigger strong immune responses (pyrogenic reactions) that can be misinterpreted as allergic reactions.

Purity and low endotoxin levels reduce allergenicity from contamination.

Injectable peptides are reconstituted in solvents (water, saline, buffers). Lyophilised (freeze-dried) peptides may contain excipients (stabilizers, bulking agents like mannitol or glucose) to maintain stability during storage. Some individuals may be allergic to excipients (e.g., sorbitol, lactose).

Request information on all components before using a peptide preparation.

Formal allergen testing (skin prick tests, IgE serology) may detect allergies to specific peptides or their components. If a previous allergic reaction occurred, testing can identify the specific allergen.

Patch testing (for contact allergy) may also be relevant for topical peptides.

Request full ingredient lists from suppliers. Ask about common allergens (nuts, dairy, eggs, soy, etc.). If allergic reactions have occurred previously, request a less contaminated or allergen-free preparation. Consider starting with a very small test dose to assess tolerability before use.